<html>
<head>
  <title>Schedule II [Code of Federal Regulations]</title>
  <basefont face="Tahoma" size="2" />
  <meta http-equiv="Content-Type" content="text/html;charset=utf-8" />
  <meta name="exporter-version" content="Evernote Windows/307027 (en-US, DDL); Windows/10.0.0 (Win64);"/>
  <style>
    body, td {
      font-family: Tahoma;
      font-size: 10pt;
    }
  </style>
</head>
<body>
<a name="5593"/>
<h1>Schedule II [Code of Federal Regulations]</h1>
<div>
<table bgcolor="#D4DDE5" border="0">
<tr><td><b>Created:</b></td><td><i>1/5/2018 7:09 PM</i></td></tr>
<tr><td><b>Updated:</b></td><td><i>1/5/2018 7:10 PM</i></td></tr>
<tr><td><b>Author:</b></td><td><i>David Patrone</i></td></tr>
<tr><td><b>Source:</b></td><td><a href="https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=1308.12"><i>https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=1308.12</i></a></td></tr>
</table>
</div>
<br/>

<div>
<span><div><table><colgroup><col></col></colgroup><tbody><tr valign="top"><td><table cellpadding="0" cellspacing="0"><colgroup><col></col></colgroup><tbody><tr><td><div>[Code of Federal Regulations]</div></td></tr><tr><td><div>[Title 21, Volume 9]</div></td></tr><tr><td><div>[Revised as of April 1, 2017]</div></td></tr><tr><td><div>[CITE: 21CFR1308.12]</div></td></tr></tbody></table></td></tr></tbody></table><div><br/></div><div><br/></div><div><br/></div><table><colgroup><col></col></colgroup><tbody><tr valign="top"><td><table align="center" cellpadding="0" cellspacing="0"><colgroup><col></col></colgroup><tbody><tr valign="top"><td align="center"><div>TITLE 21--FOOD AND DRUGS</div></td></tr></tbody></table></td></tr><tr valign="top"><td><table align="center" cellpadding="0" cellspacing="0"><colgroup><col></col></colgroup><tbody><tr><td align="center"><div>CHAPTER II--DRUG ENFORCEMENT ADMINISTRATION</div><div>DEPARTMENT OF JUSTICE</div></td></tr></tbody></table></td></tr><tr valign="top"><td><table align="center" cellpadding="0" cellspacing="0"><colgroup><col></col></colgroup><tbody><tr valign="bottom"><td align="center"><div><br/></div></td></tr></tbody></table></td></tr></tbody></table><div><a href="https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=1308">PART 1308 -- SCHEDULES OF CONTROLLED SUBSTANCES</a></div><div><span>Schedules</span></div><table><colgroup><col></col></colgroup><tbody><tr valign="top"><td><div>Sec. 1308.12 Schedule II.</div></td></tr></tbody></table><table><colgroup><col></col></colgroup><tbody><tr valign="top"><td><div><span>(a) Schedule II shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. Each drug or substance has been assigned the Controlled Substances Code Number set forth opposite it.</span></div><div><span>(b)</span><span> </span><span>Substances, vegetable origin or chemical synthesis.</span><span> </span><span>Unless specifically excepted or unless listed in another schedule, any of the following substances whether produced directly or indirectly by extraction from substances of vegetable origin, or independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis:</span></div><div><span>(1) Opium and opiate, and any salt, compound, derivative, or preparation of opium or opiate excluding apomorphine, thebaine-derived butorphanol, dextrorphan, nalbuphine, nalmefene, naloxegol, naloxone, and naltrexone, and their respective salts, but including the following:</span></div><table border="1"><colgroup><col></col><col></col></colgroup><tbody><tr><td align="left"><div>(i) Codeine</div></td><td align="right"><div>9050</div></td></tr><tr><td align="left"><div>(ii) Dihydroetorphine</div></td><td align="right"><div>9334</div></td></tr><tr><td align="left"><div>(iii) Ethylmorphine</div></td><td align="right"><div>9190</div></td></tr><tr><td align="left"><div>(iv) Etorphine hydrochloride</div></td><td align="right"><div>9059</div></td></tr><tr><td align="left"><div>(v) Granulated opium</div></td><td align="right"><div>9640</div></td></tr><tr><td align="left"><div>(vi) Hydrocodone</div></td><td align="right"><div>9193</div></td></tr><tr><td align="left"><div>(vii) Hydromorphone</div></td><td align="right"><div>9150</div></td></tr><tr><td align="left"><div>(viii) Metopon</div></td><td align="right"><div>9260</div></td></tr><tr><td align="left"><div>(ix) Morphine</div></td><td align="right"><div>9300</div></td></tr><tr><td align="left"><div>(x) Opium extracts</div></td><td align="right"><div>9610</div></td></tr><tr><td align="left"><div>(xi) Opium fluid</div></td><td align="right"><div>9620</div></td></tr><tr><td align="left"><div>(xii) Oripavine</div></td><td align="right"><div>9330</div></td></tr><tr><td align="left"><div>(xiii) Oxycodone</div></td><td align="right"><div>9143</div></td></tr><tr><td align="left"><div>(xiv) Oxymorphone</div></td><td align="right"><div>9652</div></td></tr><tr><td align="left"><div>(xv) Powdered opium</div></td><td align="right"><div>9639</div></td></tr><tr><td align="left"><div>(xvi) Raw opium</div></td><td align="right"><div>9600</div></td></tr><tr><td align="left"><div>(xvii) Thebaine</div></td><td align="right"><div>9333</div></td></tr><tr><td align="left"><div>(xviii) Tincture of opium</div></td><td align="right"><div>9630</div></td></tr></tbody></table><div><span>(2) Any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of the substances referred to in paragraph (b) (1) of this section, except that these substances shall not include the isoquinoline alkaloids of opium.</span></div><div><span>(3) Opium poppy and poppy straw.</span></div><div><span>(4) Coca leaves (9040) and any salt, compound, derivative or preparation of coca leaves (including cocaine (9041) and ecgonine (9180) and their salts, isomers, derivatives and salts of isomers and derivatives), and any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of these substances, except that the substances shall not include:</span></div><div><span>(i) Decocainized coca leaves or extraction of coca leaves, which extractions do not contain cocaine or ecgonine; or</span></div><div><span>(ii) [</span><span> </span><span>123</span><span>I]ioflupane.</span></div><div><span>(5) Concentrate of poppy straw (the crude extract of poppy straw in either liquid, solid or powder form which contains the phenanthrene alkaloids of the opium poppy), 9670.</span></div><div><span>(c)</span><span> </span><span>Opiates.</span><span> </span><span>Unless specifically excepted or unless in another schedule any of the following opiates, including its isomers, esters, ethers, salts and salts of isomers, esters and ethers whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation, dextrorphan and levopropoxyphene excepted:</span></div><table border="1"><colgroup><col></col><col></col></colgroup><tbody><tr><td align="left"><div>(1) Alfentanil</div></td><td align="right"><div>9737</div></td></tr><tr><td align="left"><div>(2) Alphaprodine</div></td><td align="right"><div>9010</div></td></tr><tr><td align="left"><div>(3) Anileridine</div></td><td align="right"><div>9020</div></td></tr><tr><td align="left"><div>(4) Bezitramide</div></td><td align="right"><div>9800</div></td></tr><tr><td align="left"><div>(5) Bulk dextropropoxyphene (non-dosage forms)</div></td><td align="right"><div>9273</div></td></tr><tr><td align="left"><div>(6) Carfentanil</div></td><td align="right"><div>9743</div></td></tr><tr><td align="left"><div>(7) Dihydrocodeine</div></td><td align="right"><div>9120</div></td></tr><tr><td align="left"><div>(8) Diphenoxylate</div></td><td align="right"><div>9170</div></td></tr><tr><td align="left"><div>(9) Fentanyl</div></td><td align="right"><div>9801</div></td></tr><tr><td align="left"><div>(10) Isomethadone</div></td><td align="right"><div>9226</div></td></tr><tr><td align="left"><div>(11) Levo-alphacetylmethadol</div></td><td align="right"><div>9648</div></td></tr><tr><td align="left"><div>[Some other names: levo-alpha-acetylmethadol, levomethadyl acetate, LAAM]</div></td><td align="right"><div><br/></div></td></tr><tr><td align="left"><div>(12) Levomethorphan</div></td><td align="right"><div>9210</div></td></tr><tr><td align="left"><div>(13) Levorphanol</div></td><td align="right"><div>9220</div></td></tr><tr><td align="left"><div>(14) Metazocine</div></td><td align="right"><div>9240</div></td></tr><tr><td align="left"><div>(15) Methadone</div></td><td align="right"><div>9250</div></td></tr><tr><td align="left"><div>(16) Methadone-Intermediate, 4-cyano-2-dimethylamino-4,4-diphenyl butane</div></td><td align="right"><div>9254</div></td></tr><tr><td align="left"><div>(17) Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic acid</div></td><td align="right"><div>9802</div></td></tr><tr><td align="left"><div>(18) Pethidine (meperidine)</div></td><td align="right"><div>9230</div></td></tr><tr><td align="left"><div>(19) Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine</div></td><td align="right"><div>9232</div></td></tr><tr><td align="left"><div>(20) Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate</div></td><td align="right"><div>9233</div></td></tr><tr><td align="left"><div>(21) Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid</div></td><td align="right"><div>9234</div></td></tr><tr><td align="left"><div>(22) Phenazocine</div></td><td align="right"><div>9715</div></td></tr><tr><td align="left"><div>(23) Piminodine</div></td><td align="right"><div>9730</div></td></tr><tr><td align="left"><div>(24) Racemethorphan</div></td><td align="right"><div>9732</div></td></tr><tr><td align="left"><div>(25) Racemorphan</div></td><td align="right"><div>9733</div></td></tr><tr><td align="left"><div>(26) Remifentanil</div></td><td align="right"><div>9739</div></td></tr><tr><td align="left"><div>(27) Sufentanil</div></td><td align="right"><div>9740</div></td></tr><tr><td align="left"><div>(28) Tapentadol</div></td><td align="right"><div>9780</div></td></tr><tr><td align="left"><div>(29) Thiafentanil</div></td><td align="right"><div>9729</div></td></tr></tbody></table><div><span>(d)</span><span> </span><span>Stimulants.</span><span> </span><span>Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system:</span></div><table border="1"><colgroup><col></col><col></col></colgroup><tbody><tr><td align="left"><div>(1) Amphetamine, its salts, optical isomers, and salts of its optical isomers</div></td><td align="right"><div>1100</div></td></tr><tr><td align="left"><div>(2) Methamphetamine, its salts, isomers, and salts of its isomers</div></td><td align="right"><div>1105</div></td></tr><tr><td align="left"><div>(3) Phenmetrazine and its salts</div></td><td align="right"><div>1631</div></td></tr><tr><td align="left"><div>(4) Methylphenidate</div></td><td align="right"><div>1724</div></td></tr><tr><td align="left"><div>(5) Lisdexamfetamine, its salts, isomers, and salts of its isomers</div></td><td align="right"><div>1205.</div></td></tr></tbody></table><div><span>(e)</span><span> </span><span>Depressants.</span><span> </span><span>Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:</span></div><table border="1"><colgroup><col></col><col></col></colgroup><tbody><tr><td align="left"><div>(1) Amobarbital</div></td><td align="right"><div>2125</div></td></tr><tr><td align="left"><div>(2) Glutethimide</div></td><td align="right"><div>2550</div></td></tr><tr><td align="left"><div>(3) Pentobarbital</div></td><td align="right"><div>2270</div></td></tr><tr><td align="left"><div>(4) Phencyclidine</div></td><td align="right"><div>7471</div></td></tr><tr><td align="left"><div>(5) Secobarbital</div></td><td align="right"><div>2315</div></td></tr></tbody></table><div><span>(f)</span><span> </span><span>Hallucinogenic substances.</span></div><table border="1"><colgroup><col></col><col></col></colgroup><tbody><tr><td align="left"><div>(1) Nabilone</div></td><td align="right"><div>7379</div></td></tr><tr><td align="left"><div>[Another name for nabilone: (+/-)-trans-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6,6-dimethyl-9H-dibenzo[b,d]pyran-9-one]</div></td><td align="right"><div><br/></div></td></tr><tr><td align="left"><div>(2) Dronabinol [(-)-delta-9-trans tetrahydrocannabinol] in an oral solution in a drug product approved for marketing by the U.S. Food and Drug Administration</div></td><td align="right"><div>(7365)</div></td></tr></tbody></table><div><span>(g)</span><span> </span><span>Immediate precursors.</span><span> </span><span>Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances:</span></div><div><span>(1) Immediate precursor to amphetamine and methamphetamine:</span></div><table border="1"><colgroup><col></col><col></col></colgroup><tbody><tr><td align="left"><div>(i) Phenylacetone</div></td><td align="right"><div>8501</div></td></tr><tr><td align="left"><div>Some trade or other names: phenyl-2-propanone; P2P; benzyl methyl ketone; methyl benzyl ketone;</div></td><td align="right"><div><br/></div></td></tr></tbody></table><div><span>(2) Immediate precursors to phencyclidine (PCP):</span></div><table border="1"><colgroup><col></col><col></col></colgroup><tbody><tr><td align="left"><div>(i) 1-phenylcyclohexylamine</div></td><td align="right"><div>7460</div></td></tr><tr><td align="left"><div>(ii) 1-piperidinocyclohexanecarbonitrile (PCC)</div></td><td align="right"><div>8603</div></td></tr></tbody></table><div><span>(3) Immediate precursor to fentanyl:</span></div><table border="1"><colgroup><col></col><col></col></colgroup><tbody><tr><td align="left"><div>(i) 4-anilino-N-phenethyl-4-piperidine (ANPP)</div></td><td align="right"><div>8333</div></td></tr></tbody></table><div><span>(ii) [Reserved]</span></div><div><span>[39 FR 22142, June 20, 1974]</span></div><div><span>Editorial Note:</span></div><div><span>For Federal Register citations affecting 1308.12, see the List of CFR Sections Affected, which appears in the Finding Aids section of the printed volume and at</span><span> </span><span><a href="http://www.fdsys.gov/">www.fdsys.gov</a>.</span></div></td></tr></tbody></table><div><br/></div></div></span>
</div></body></html> 